EchoIQ Limited (AU:EIQ) has released an update.
Don't Miss our Black Friday Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Echo IQ Limited has announced the integration of its AI-driven EchoSolv-AS technology with Boston’s Beth Israel Deaconess Medical Center. This partnership follows a successful trial that demonstrated EchoSolv-AS’s ability to accurately identify patients with severe aortic stenosis. Echo IQ is also expanding its presence in the U.S. by integrating with additional hospitals across New York, Alabama, Dallas, and Oklahoma.
For further insights into AU:EIQ stock, check out TipRanks’ Stock Analysis page.
Trending Articles
- All Eyes on Nvidia Stock Ahead of Earnings; Here’s What Oppenheimer Expects
- ‘The Golden Path Is Within Reach,’ Says Daniel Ives About Tesla Stock
- ‘Next Two Years Will Be Crucial,’ Says Craig-Hallum About IonQ Stock
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
